Millennium Management
ZYNE

Millennium Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Millennium Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-206,000
Closed -$1.56M – 4742
2019
Q3 		$1.56M Buy
+206,000
New +$2.32M ﹤0.01% 2605

Millennium Management's ZYNE Position: Q4 2023 in Review

Millennium Management sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 325,237 shares — an estimated $413K sold.

Millennium Management first reported a position in ZYNE in Q1 2017 and held it in 20 quarters. The position peaked at $2.19M in Q2 2018. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

  • Millennium Management reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
  • Millennium Management sold 325,237 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $413K.
  • Millennium Management first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2017 and held it in 20 quarters.
  • Millennium Management's Zynerba Pharmaceuticals, Inc position peaked at $2.19M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.